An Overview of the Biopharmaceutical Applications of Chitosan and Alginate

BioPharm International

Volumn 16, Issue 11, 2003, Pages 34-35

  Shinn, Annie H ^a   Smith, Timothy J ^a  

^a UNIVERSITY OF THE PACIFIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID; CHITOSAN;

BIOTECHNOLOGY; DRUG STRUCTURE; MACROMOLECULE; PROTEIN MODIFICATION; REVIEW;

EID: 0242663480     PISSN: 1542166X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Synowiecki J, Al-Khateeb NA. Production, properties, and some new applications of chitin and its derivatives. Critical Reviews in Food Science and Nutrition 2003; 43(2):145-71.
2. Wu AC, Bough WA, Conrad EC, Alden KE. Determination of molecular-weight distribution of chitosan by high-performance liquid chromatography. J Chromatography 1976; 128(1):87-9.
3. Borchard G, Junginger HE. Modern drug delivery applications of chitosan. Adv Drug Deliv Rey 2001; 52(2):103.
4. Tapia C, et al. Study of the influence of the pH media dissolution, degree of polymerization, and degree of swelling of the polymers on the mechanism of release of diltiazem from matrices based on mixtures of chitosan/alginate. Drug Dev Ind Pharm 2002; 28(2):217-24.
5. Boylan HJ. The commercial exploitation of seaweeds, with special reference to alginate manufacture. Planta Med 1971; 20(2):178-80.
6. Horton JC, Harding SE, Mitchell JR. Gel permeation chromatography - multi-angle laser light scattering characterization of the molecular mass distribution of 'pronova' sodium alginate. Biochem Soc Trans 1991; 19(2):510-1.
7. Seely GR, Hart RL. The binding of alkaline earth metal ions to alginate. Macromolecules 1974; 7(5):706-10.
8. Tonnesen HH, Karlsen J. Alginate in drug delivery systems. Drug Dev Ind Pharm 2002; 28(6):621-30.
9. Gotoh T, et al. A new type porous carrier and its application to culture of suspension cells. Cytotechnology 1993; 11(1):35-40.
10. Shu XZ, Zhu KJ, Song W. Novel pH-sensitive citrate cross-linked chitosan film for drug controlled release. Int J Pharm 2001; 212(1):19-28.
11. Venkatesh S, Smith TJ. Chitosan-mediated transfection of HeLa cells. Pharm Dev Technol 1997; 2(4):417-8.
12. Borchard G. Chitosans for gene delivery. Adv Drug Deliv Rev 2001; 52(2):145-50.
13. Singla AK, Chawla M. Chitosan: some pharmaceutical and biological aspects - an update. J Pharm Pharmacol 2001; 53(8):1047-67.
14. Stabler C, et al. The effects of alginate composition on encapsulated betaTC3 cells. Biomaterials 2001; 22(11):1301-10.
15. Erbacher P, et al. Chitosan-based vector/DNA complexes for gene delivery: biophysical characteristics and transfection ability. Pharm Res 1998; 15(9):1332-9.
16. Venkatesh S, Smith TJ. Chitosan-membrane interactions and their probable role in chitosan-mediated transfection. Biotechnol Appl Biochem 1998; 27(Pt. 3):265-7.
17. Padmanabhan K, Smith TJ. A preliminary investigation of modified alginates as a matrix for gene transfection in a HeLa cell model. Pharm Dev Technol 2002; 7(1):97-101.
18. Wang L, Khor E, Lim LY. Chitosan-alginate-CaCl(2) system for membrane coat application. J Pharm Sci 2001;90(8):1134-42.
19. Coppi G, et al. Chitosan-alginate microparticles as a protein carrier. Drug Dev Ind Pharm 2001; 27(5):393-400.
20. Serp D, et al. Characterization of an encapsulation device for the production of monodisperse alginate beads for cell immobilization. Biotechnol Bioeng 2000; 70(1):41-53.